vs
FLEXSTEEL INDUSTRIES INC（FLXS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是FLEXSTEEL INDUSTRIES INC的1.7倍（$197.9M vs $115.1M），FLEXSTEEL INDUSTRIES INC净利率更高（17.7% vs 6.7%，领先11.0%），REPLIGEN CORP同比增速更快（13.6% vs 1.0%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 1.9%）
Flexsteel Industries Inc是一家总部位于美国的家具制造商，设计、生产并销售各类软垫住宅家具、商用家具及酒店家具，主要面向北美市场运营，通过广泛的分销网络服务终端消费者、零售合作伙伴及企业客户。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FLXS vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$115.1M
营收增速更快
RGEN
高出12.6%
1.0%
净利率更高
FLXS
高出11.0%
6.7%
两年增速更快
RGEN
近两年复合增速
1.9%
损益表 — Q1 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.1M | $197.9M |
| 净利润 | $20.4M | $13.3M |
| 毛利率 | 22.6% | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 17.7% | 6.7% |
| 营收同比 | 1.0% | 13.6% |
| 净利润同比 | 116.0% | 143.9% |
| 每股收益（稀释后） | $1.14 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLXSRGEN
| Q3 26 | $115.1M | — | ||
| Q4 25 | $118.2M | $197.9M | ||
| Q3 25 | $110.4M | $188.8M | ||
| Q2 25 | $114.6M | $182.4M | ||
| Q1 25 | $114.0M | $169.2M | ||
| Q4 24 | $108.5M | $174.1M | ||
| Q3 24 | $104.0M | $154.9M | ||
| Q2 24 | $110.8M | $154.1M |
净利润FLXSRGEN
| Q3 26 | $20.4M | — | ||
| Q4 25 | $6.6M | $13.3M | ||
| Q3 25 | $7.3M | $14.9M | ||
| Q2 25 | $10.7M | $14.9M | ||
| Q1 25 | $-3.7M | $5.8M | ||
| Q4 24 | $9.1M | $-30.3M | ||
| Q3 24 | $4.1M | $-654.0K | ||
| Q2 24 | $4.9M | $3.3M |
毛利率FLXSRGEN
| Q3 26 | 22.6% | — | ||
| Q4 25 | 22.7% | 52.5% | ||
| Q3 25 | 23.5% | 53.2% | ||
| Q2 25 | 23.9% | 50.0% | ||
| Q1 25 | 22.2% | 53.6% | ||
| Q4 24 | 21.0% | 26.1% | ||
| Q3 24 | 21.5% | 50.0% | ||
| Q2 24 | 21.3% | 49.8% |
营业利润率FLXSRGEN
| Q3 26 | — | — | ||
| Q4 25 | 7.6% | 9.0% | ||
| Q3 25 | 8.1% | 8.9% | ||
| Q2 25 | 12.2% | 7.6% | ||
| Q1 25 | -4.4% | 3.9% | ||
| Q4 24 | 10.7% | -17.7% | ||
| Q3 24 | 5.8% | -5.1% | ||
| Q2 24 | 6.9% | 1.0% |
净利率FLXSRGEN
| Q3 26 | 17.7% | — | ||
| Q4 25 | 5.6% | 6.7% | ||
| Q3 25 | 6.6% | 7.9% | ||
| Q2 25 | 9.3% | 8.2% | ||
| Q1 25 | -3.3% | 3.4% | ||
| Q4 24 | 8.3% | -17.4% | ||
| Q3 24 | 4.0% | -0.4% | ||
| Q2 24 | 4.4% | 2.2% |
每股收益（稀释后）FLXSRGEN
| Q3 26 | $1.14 | — | ||
| Q4 25 | $1.18 | $0.24 | ||
| Q3 25 | $1.31 | $0.26 | ||
| Q2 25 | $1.90 | $0.26 | ||
| Q1 25 | $-0.71 | $0.10 | ||
| Q4 24 | $1.62 | $-0.55 | ||
| Q3 24 | $0.74 | $-0.01 | ||
| Q2 24 | $0.87 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $185.3M | $2.1B |
| 总资产 | $290.2M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FLXSRGEN
| Q3 26 | $57.3M | — | ||
| Q4 25 | $36.8M | $767.6M | ||
| Q3 25 | $38.6M | $748.7M | ||
| Q2 25 | $40.0M | $708.9M | ||
| Q1 25 | $22.6M | $697.2M | ||
| Q4 24 | $11.8M | $757.4M | ||
| Q3 24 | $5.7M | $784.0M | ||
| Q2 24 | $4.8M | $809.1M |
总债务FLXSRGEN
| Q3 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FLXSRGEN
| Q3 26 | $185.3M | — | ||
| Q4 25 | $178.9M | $2.1B | ||
| Q3 25 | $172.2M | $2.1B | ||
| Q2 25 | $167.9M | $2.1B | ||
| Q1 25 | $158.1M | $2.0B | ||
| Q4 24 | $161.9M | $2.0B | ||
| Q3 24 | $154.7M | $2.0B | ||
| Q2 24 | $150.4M | $2.0B |
总资产FLXSRGEN
| Q3 26 | $290.2M | — | ||
| Q4 25 | $290.2M | $2.9B | ||
| Q3 25 | $281.5M | $2.9B | ||
| Q2 25 | $282.5M | $2.9B | ||
| Q1 25 | $266.1M | $2.9B | ||
| Q4 24 | $271.5M | $2.8B | ||
| Q3 24 | $268.7M | $2.8B | ||
| Q2 24 | $274.5M | $2.9B |
负债/权益比FLXSRGEN
| Q3 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 1.33× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流FLXSRGEN
| Q3 26 | $27.2M | — | ||
| Q4 25 | $1.0M | $25.7M | ||
| Q3 25 | $4.1M | $48.1M | ||
| Q2 25 | $15.6M | $28.6M | ||
| Q1 25 | $12.3M | $15.0M | ||
| Q4 24 | $6.7M | $39.2M | ||
| Q3 24 | $2.4M | $49.3M | ||
| Q2 24 | $7.5M | $42.2M |
自由现金流FLXSRGEN
| Q3 26 | — | — | ||
| Q4 25 | $-735.0K | $17.6M | ||
| Q3 25 | $2.8M | $43.4M | ||
| Q2 25 | $15.1M | $21.5M | ||
| Q1 25 | $10.9M | $11.4M | ||
| Q4 24 | $5.8M | $33.6M | ||
| Q3 24 | $2.0M | $42.3M | ||
| Q2 24 | $7.1M | $37.4M |
自由现金流率FLXSRGEN
| Q3 26 | — | — | ||
| Q4 25 | -0.6% | 8.9% | ||
| Q3 25 | 2.5% | 23.0% | ||
| Q2 25 | 13.1% | 11.8% | ||
| Q1 25 | 9.6% | 6.8% | ||
| Q4 24 | 5.3% | 19.3% | ||
| Q3 24 | 1.9% | 27.3% | ||
| Q2 24 | 6.4% | 24.3% |
资本支出强度FLXSRGEN
| Q3 26 | — | — | ||
| Q4 25 | 1.5% | 4.1% | ||
| Q3 25 | 1.2% | 2.5% | ||
| Q2 25 | 0.5% | 3.9% | ||
| Q1 25 | 1.2% | 2.1% | ||
| Q4 24 | 0.8% | 3.2% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 0.4% | 3.1% |
现金转化率FLXSRGEN
| Q3 26 | 1.33× | — | ||
| Q4 25 | 0.15× | 1.93× | ||
| Q3 25 | 0.56× | 3.23× | ||
| Q2 25 | 1.46× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 1.53× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
